Regeneron Announces the 2022 Winners of the Regeneron Prize for Creative Innovation
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the 10th annual Regeneron Prize for Creative Innovation, a competition designed to recognize excellence and creativity in biomedical research conducted by postdoctoral fellows and graduate students. Each year, Regeneron invites the ...
Source: pharmiweb.com